SLC22A1 Produits
(Solute Carrier Family 22 (Organic Cation Transporter), Member 1 (SLC22A1))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories SLC22A1 en vedette
SLC22A1 Anticorps
High quality antibodies with extensive validation data.
SLC22A1 Kits ELISA
Reliable ELISA kits for a wide range of species.
SLC22A1 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
SLC22A1 recommandé Anticorps
- (3)
- (3)
- (2)
- (2)
SLC22A1 recommandé Kits ELISA
SLC22A1 recommandé Protéines
Dernières publications sur nos produits SLC22A1
: "Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB)." dans: PLoS ONE, Vol. 12, Issue 3, pp. e0173474, (2017) (PubMed).: "Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomers." dans: PLoS ONE, Vol. 12, Issue 6, pp. e0180257, (2017) (PubMed).
: "Fine Mapping and Functional Analysis Reveal a Role of SLC22A1 in Acylcarnitine Transport." dans: American journal of human genetics, Vol. 101, Issue 4, pp. 489-502, (2017) (PubMed).
: "The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin." dans: Scientific reports, Vol. 6, pp. 20508, (2016) (PubMed).
: "Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1." dans: Genome medicine, Vol. 7, Issue 1, pp. 56, (2015) (PubMed).
: "The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier." dans: Molecular pharmaceutics, Vol. 11, Issue 3, pp. 995-1006, (2014) (PubMed).
: "Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake." dans: Drug metabolism and disposition: the biological fate of chemicals, Vol. 42, Issue 6, pp. 990-5, (2014) (PubMed).
: "OCT1 (SLC22A1) R61C polymorphism and response to imatinib treatment in chronic myeloid leukemia patients." dans: Leukemia & lymphoma, Vol. 49, Issue 11, pp. 2222-3, (2008) (PubMed).
: "Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells." dans: Pharmaceutical research, Vol. 25, Issue 4, pp. 827-35, (2008) (PubMed).
: "Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia." dans: Blood, Vol. 112, Issue 8, pp. 3348-54, (2008) (PubMed).
Synonymes et noms alternatifs relatifs à SLC22A1
solute carrier family 22 member 1 (SLC22A1), solute carrier family 22 (organic cation transporter), member 1 (Slc22a1), solute carrier family 22 member 1 (Slc22a1), solute carrier family 22 member 2-like (LOC421584), HOCT1, Lx1, OCT1, Oct1, oct1_cds, Orct, Orct1, Roct1, SLC22A1, SLC22A2Protein level used designations for SLC22A1
- solute carrier family 22 member 1
- solute carrier family 22 (organic cation transporter), member 1
- solute carrier family 22 member 1-like
- pOCT1
- organic cation transporter 1
- mOCT1
- solute carrier family 22, member 1
- solute carrier family 22 (organic cation transporter), member 2